Hallym Pharmaceutical

Hallym Pharmaceutical is a prominent South Korean pharmaceutical company established in 1974, specializing in the development, manufacturing, and marketing of a diverse range of therapeutic products. The company is a recognized leader in the domestic ophthalmology market, providing a comprehensive suite of treatments for conditions such as glaucoma and macular degeneration. Beyond eye care, Hallym maintains a strong presence in circulatory system medications, musculoskeletal treatments, and gastrointestinal health. With advanced GMP-certified manufacturing facilities and a dedicated research and development center, the company focuses on both innovative drug discovery and high-quality generic formulations. Hallym is actively expanding its global footprint through international exports and contract development and manufacturing services.